Data / Research funding / Endometriosis
Endometriosis: 108 NIH awards ($124.5M) to 58 organizations
108 NIH awards ($124.5M) in the NIH spending category Endometriosis, to 58 organizations, read 2026-11-04. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
108 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| UCSF Stanford Endometriosis Center for Discovery, Innovation, Training and Community Engagement | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $7,144,473 | August 1, 2021 | July 31, 2027 | GIUDICE, LINDA C | reporter.nih.gov |
| Relating Molecular Subgroups of Endometriosis-Associated Ovarian Cancers to Survival and Risk | NIH | National Cancer Institute | 2021 to 2025 | $4,355,861 | January 13, 2021 | December 31, 2026 | GOODE, ELLEN L. | reporter.nih.gov |
| Novel, Non-hormonal Therapeutic for Endometriosis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $4,343,450 | September 1, 2019 | August 31, 2025 | PETROSSIAN, TANYA CHRISTINEH | reporter.nih.gov |
| Pre-IVF treatment with a GnRH antagonist in women with endometriosis - A prospective double blind placebo controlled trial (Pregnant) - Application 1/4 | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $3,487,938 | September 26, 2019 | June 30, 2025 | TAYLOR, HUGH SMITH | reporter.nih.gov |
| Mechanisms and interventions addressing accelerated cardiovascular disease risk in women with endometriosis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,309,680 | January 5, 2022 | December 31, 2026 | ALEXANDER, LACY M. | reporter.nih.gov |
| REST/NRSF, miRNAs, and tissue remodeling in adenomyosis pathophysiology | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $3,129,764 | August 9, 2021 | April 30, 2027 | NOTHNICK, WARREN B | reporter.nih.gov |
| Individual differences in brain morphology and connectivity to identify the mechanisms of comorbidities and treatment-refractory disease in females with endometriosis-associated pelvic pain | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $2,969,745 | August 1, 2025 | July 31, 2028 | SCHREPF, ANDREW | reporter.nih.gov |
| CMG2 as a target for safe and effective treatment of endometriosis-associate pain | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,887,122 | September 20, 2022 | August 31, 2027 | ROGERS, MICHAEL SEAN | reporter.nih.gov |
| Discovery and development of potent inhibitors of Jun N-terminal kinase for non-hormonal treatment of endometriosis and associated pain | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $2,824,721 | August 11, 2021 | May 31, 2026 | MONSIVAIS, DIANA | reporter.nih.gov |
| Regulation of Endometriotic Lesion Development by NOTCH1 | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $2,751,967 | April 1, 2021 | February 28, 2027 | FAZLEABAS, ASGERALLY T. | reporter.nih.gov |
| Kinases as Therapeutic Targets for Endometriosis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,743,980 | August 1, 2022 | April 30, 2027 | MATZUK, MARTIN M. | reporter.nih.gov |
| Identifying plasma proteomic profiles of chronic pain development in endometriosis from adolescence to adulthood | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 | $2,689,739 | September 19, 2023 | August 31, 2026 | SASAMOTO, NAOKO | reporter.nih.gov |
| Targeting cellular senescence to inhibit the development and progression of ovarian endometriomas | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,553,911 | September 15, 2022 | June 30, 2027 | HAWKINS, SHANNON MICHELLE | reporter.nih.gov |
| Life history of the menstruating uterus | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,527,271 | September 20, 2022 | August 31, 2027 | MCKINLEY, KARA LAVIDGE | reporter.nih.gov |
| Development of anti-inflammatory nanodrug for endometriosis treatment | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,492,373 | September 30, 2022 | June 30, 2027 | KIM, TAEHO | reporter.nih.gov |
| Novel biomarkers and pathways of persistent endometriosis-associated pain across the life course | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $2,430,576 | March 23, 2023 | February 29, 2028 | AS-SANIE, SAWSAN | reporter.nih.gov |
| Development of magnetic hyperthermia for the systemic treatment of endometriosis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $2,416,419 | September 17, 2021 | August 31, 2025 | TARATULA, OLEH | reporter.nih.gov |
| Endometriosis Diagnosis and Subtypes, Reproductive History, and Cardiovascular Disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,389,602 | May 9, 2023 | April 30, 2028 | SCHLIEP, KAREN C. | reporter.nih.gov |
| Complex inflammatory mechanisms and therapeutic targeting in endometriosis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $2,360,570 | April 1, 2021 | March 31, 2027 | HAYASHI, KANAKO | reporter.nih.gov |
| Molecular mechanisms of gap junction promotion of lesion formation in Endometriosis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $2,305,167 | September 17, 2021 | June 30, 2027 | NICHOLSON, BRUCE J | reporter.nih.gov |
| What is Endometriosis? Deep Phenotyping to Advance Diagnosis and Treatment | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $2,201,801 | August 1, 2018 | April 30, 2025 | FAZLEABAS, ASGERALLY T. | reporter.nih.gov |
| The cytokine code and neural circuits for sensing inflammation state | NIH | National Institute of Mental Health | 2024 to 2025 | $2,177,000 | September 30, 2024 | July 31, 2029 | KEPECS, ADAM | reporter.nih.gov |
| Epigenetic regulation of receptive endometrium | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,135,823 | September 1, 2022 | January 31, 2026 | JEONG, JAE-WOOK | reporter.nih.gov |
| Novel, Non-hormonal Therapeutic for Endometriosis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $2,045,782 | April 10, 2025 | March 31, 2027 | PETROSSIAN, TANYA CHRISTINEH | reporter.nih.gov |
| Integrative risk modeling for early prediction of endometriosis and its long-term health outcomes | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $2,028,472 | May 15, 2023 | February 29, 2028 | VERMA, SHEFALI SETIA | reporter.nih.gov |
| Role of cancer-associated mutations in endometriosis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $2,005,345 | July 17, 2019 | January 31, 2026 | SEGARS, JAMES H. | reporter.nih.gov |
| Targeting the endometrial stem cell niche inendometriosis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $1,966,296 | August 9, 2022 | May 31, 2027 | MONSIVAIS, DIANA | reporter.nih.gov |
| The impact of hormonal modulation on systemic inflammation and central sensitization | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $1,933,439 | September 20, 2023 | August 31, 2028 | AS-SANIE, SAWSAN | reporter.nih.gov |
| Microvascular Permeability, Inflammation, and Lesion Physiology in Endometriosis: A Microphysiological Systems Approach | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2023 | $1,720,147 | September 30, 2019 | June 30, 2024 | GRIFFITH, LINDA G | reporter.nih.gov |
| Microphysiological modeling of Endometriosis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $1,681,646 | September 25, 2023 | June 30, 2027 | KIM, JI-YONG JULIE | reporter.nih.gov |
| Epigenetic regulatory mechanisms and therapeutic opportunities in endometriosis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $1,679,010 | August 15, 2021 | June 30, 2027 | CHANDLER, RONALD L | reporter.nih.gov |
| Mechanistic Characterization of Uterine Pain (M-CUP) to improve diagnosis and treatment for dysmenorrhea | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $1,562,776 | September 6, 2019 | August 31, 2025 | HELLMAN, KEVIN | reporter.nih.gov |
| Developing a non-invasive, definitive diagnostic for endometriosis using biomarkers in menstrual effluence | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2023 | $1,510,006 | February 15, 2022 | May 31, 2024 | GIRE, STEPHEN | reporter.nih.gov |
| Role of the gut microbiota in endometriosis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $1,507,717 | April 1, 2021 | March 31, 2027 | KOMMAGANI, RAMAKRISHNA | reporter.nih.gov |
| The Genomic Function of Estrogen Receptor Beta in Endometriosis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $1,506,073 | March 6, 2020 | December 31, 2025 | HAN, SANG JUN | reporter.nih.gov |
| Disentangling the genetic mechanisms of endometriosis severity with single-cell multi-omics | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $1,431,222 | September 1, 2024 | May 31, 2029 | LAWRENSON, KATE | reporter.nih.gov |
| Parsing the Interplay Between Biophysical and Biochemical Microenvironment Cues On Endometriosis Lesion Phenotypes Using Microphysiological Systems | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $1,311,653 | March 25, 2022 | February 28, 2027 | GRIFFITH, LINDA G | reporter.nih.gov |
| Roles of GATA Transcription Factors in Endometriosis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $1,308,171 | February 5, 2024 | November 30, 2028 | CHAKRAVARTI, DEBABRATA | reporter.nih.gov |
| Phytotherapy for Endometriosis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $1,299,643 | September 1, 2022 | May 31, 2027 | AROSH, JOE A. | reporter.nih.gov |
| The Role of the Matrisome in Endometriosis Development | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $1,291,740 | September 13, 2019 | May 31, 2026 | BURNS, KATHERINE ANNE | reporter.nih.gov |
| Phase II- Repurposing CRH antagonists for the treatment of endometriosis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $1,239,987 | June 1, 2023 | April 30, 2027 | TORRES-REVERON, ANNELYN | reporter.nih.gov |
| Functional Genomics Across an Ethnically and Racially Diverse Endometriosis Population | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $1,165,985 | July 16, 2024 | December 31, 2028 | LAWRENSON, KATE | reporter.nih.gov |
| Investigating Mixtures of Pollutants and Endometriosis in Tissue (IMPLANT) Study | NIH | National Institute of Environmental Health Sciences | 2021 to 2024 | $1,071,007 | February 1, 2020 | November 30, 2025 | POLLACK, ANNA ZULEMA | reporter.nih.gov |
| Hormonal Influences on Inflammation in Endometriosis | NIH | National Human Genome Research Institute | 2024 to 2025 | $956,519 | September 25, 2024 | July 31, 2028 | LAWRENSON, KATE | reporter.nih.gov |
| An AHEI Dietary Intervention to Reduce Pain in Women with Endometriosis | NIH | National Institute of Nursing Research | 2021 to 2023 | $897,951 | February 11, 2019 | December 31, 2024 | HARRIS, HOLLY RUTH | reporter.nih.gov |
| Pre-IVF treatment with a GnRH antagonist in women with endometriosis - A prospective double blind placebo controlled trial 2/3 | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $800,046 | September 26, 2019 | June 30, 2025 | SANTORO, NANETTE F. | reporter.nih.gov |
| Molecular Imaging and Diagnosis of Endometriosis using Mass Spectrometry Technologies | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $771,515 | September 1, 2021 | March 31, 2025 | SCHIAVINATO EBERLIN, LIVIA | reporter.nih.gov |
| Epigenetic regulation of receptive endometrium | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $768,010 | April 15, 2021 | August 31, 2022 | JEONG, JAE-WOOK | reporter.nih.gov |
| Performance evaluation of a non-invasive menstrual test for endometriosis in infertility patients | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $759,944 | April 15, 2025 | March 31, 2028 | GIRE, STEPHEN | reporter.nih.gov |
| Transcriptomic Changes during early endometriotic lesion development | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $716,192 | September 12, 2025 | August 31, 2030 | BURNS, GREGORY WILLIS | reporter.nih.gov |
| PhendoPHL:A Data-Science Enabled Personal Health Library to Manage Endometriosis | NIH | National Library of Medicine | 2021 to 2022 | $704,700 | February 7, 2019 | January 31, 2025 | ELHADAD, NOEMIE | reporter.nih.gov |
| 3/4: Pre-IVF treatment with a GnRH antagonist in women with endometriosis - A prospective double blind placebo controlled trial (PREGNANT) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $647,053 | September 26, 2019 | June 30, 2025 | JUNGHEIM, EMILY S | reporter.nih.gov |
| Physiomimetic Models of Endometrioma Initiation | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $643,049 | March 19, 2025 | December 31, 2029 | HARLEY, BRENDAN A. | reporter.nih.gov |
| Revealing Cilia Function in the Human Fallopian Tubes | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $609,400 | August 12, 2025 | April 30, 2030 | BARTON, JENNIFER KEHLET | reporter.nih.gov |
| The role of fallopian tube microbiome in ovarian carcinogenesis | NIH | National Cancer Institute | 2021 to 2023 | $588,636 | March 1, 2023 | February 29, 2024 | YU, BO | reporter.nih.gov |
| Ion Channels Critical for Uterine Contraction, Reproduction, and Adenomyosis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $584,074 | June 1, 2025 | February 28, 2030 | ZHUGE, RONGHUA | reporter.nih.gov |
| STING inhibition as a therapeutic target for endometriosis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $578,397 | July 7, 2025 | March 31, 2030 | VILLACORTA, LUIS | reporter.nih.gov |
| Peripheral and Central Nervous System Correlates of Persistent Post-Hysterectomy Pain | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $537,158 | June 1, 2017 | February 29, 2024 | AS-SANIE, SAWSAN | reporter.nih.gov |
| Delineating the role of ALDH2 in endometriosis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $528,473 | August 1, 2025 | April 30, 2029 | MCALLISTER, STACY L | reporter.nih.gov |
| Pre-IVF treatment with a GnRH antagonist in women with endometriosis - A prospective double blind placebo controlled trial (Pregnant) - Application 4/4 | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $508,679 | September 26, 2019 | May 7, 2023 | YOUNG, STEVEN L | reporter.nih.gov |
| Erythrocyte fatty acids and risk of endometriosis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2023 | $506,118 | September 22, 2022 | August 31, 2025 | HARRIS, HOLLY RUTH | reporter.nih.gov |
| Defining the structure-interactome relationships of the basigin glycoprotein in endometriosis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $506,000 | August 1, 2025 | July 31, 2027 | HUANG, MIA L | reporter.nih.gov |
| Metabolomic profiling of adolescent endometriosis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2023 | $492,250 | August 10, 2022 | July 31, 2025 | TERRY, KATHRYN L. | reporter.nih.gov |
| Identification of a Novel Target for the Treatment of Endometriosis-associated Pain | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2023 | $486,750 | September 15, 2022 | August 31, 2025 | ROGERS, MICHAEL SEAN | reporter.nih.gov |
| The Enteric Glia as a Possible Target for Symptom Relief in Endometriosis | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $470,400 | April 1, 2023 | March 31, 2027 | APPLEYARD, CAROLINE B | reporter.nih.gov |
| The non-invasive early detection of endometriosis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2024 | $464,075 | May 15, 2023 | October 31, 2025 | PETERS, DAVID GERARD | reporter.nih.gov |
| SIRT1 and BCL6: Dual Biomarkers of Endometriosis and Endometrial Receptivity | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $463,322 | February 1, 2020 | January 31, 2024 | ANGRESS, DAN | reporter.nih.gov |
| Risk factors for and consequences of endometriosis among Black women | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $461,320 | July 23, 2024 | June 30, 2027 | HARRIS, HOLLY RUTH | reporter.nih.gov |
| Single cell analytics and drug discovery at the endometrial-myometrial junction in symptomatic adenomyosis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $460,926 | August 1, 2024 | July 31, 2027 | GIUDICE, LINDA C | reporter.nih.gov |
| The contributions of inflammatory cocktail and stromal cell origin on a scaffold-free 3D biofabricated SSuPer tissue of endometriosis and normal endometrium | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $435,875 | April 1, 2021 | March 31, 2024 | HAWKINS, SHANNON MICHELLE | reporter.nih.gov |
| Photoacoustic imaging of endometriosis with nanoparticle contrast agents | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $430,063 | August 10, 2025 | July 31, 2027 | DAY, EMILY S | reporter.nih.gov |
| Pre-IVF treatment with a GnRH antagonist in women with endometriosis - A prospective double blind placebo controlled trial (Pregnant) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2023 | $429,718 | September 26, 2019 | June 30, 2025 | YOUNG, STEVEN L | reporter.nih.gov |
| Dissecting the role of RPLP1 in female reproductive tract pathologies | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2023 | $426,250 | September 15, 2022 | August 31, 2025 | NOTHNICK, WARREN B | reporter.nih.gov |
| Noninvasive and early detection of endometriosis using a biological neural circuit-based novel gas sensor | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $426,214 | August 7, 2024 | August 6, 2026 | FAZLEABAS, ASGERALLY T. | reporter.nih.gov |
| Phenotyping Responses to Optimize the Management of Pain Treatment in Endometriosis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2023 | $419,375 | September 15, 2022 | August 31, 2025 | BARTLEY, EMILY J. | reporter.nih.gov |
| Validating SER-014, a TRPV1 antagonist, to treat endometriosis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 | $384,418 | September 1, 2024 | August 31, 2025 | BHARGAVA, KUMARIL | reporter.nih.gov |
| Role of the Gut Microbiota in Endometriosis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $380,148 | April 1, 2021 | December 5, 2021 | KOMMAGANI, RAMAKRISHNA | reporter.nih.gov |
| Repurposing CRH antagonists for the treatment of endometriosis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2023 | $371,036 | June 1, 2023 | April 30, 2024 | TORRES-REVERON, ANNELYN | reporter.nih.gov |
| Development and validation of a high-fidelity gynecologic training platform for robotic-assisted surgery using 3D printing technology | NIH | National Institute of Biomedical Imaging and Bioengineering | 2023 | $371,012 | September 21, 2023 | August 31, 2024 | ZANEVELD, JACQUES E.T. | reporter.nih.gov |
| Interdisciplinary group care for the treatment of endometriosis-associated pain | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $326,005 | September 1, 2024 | August 31, 2028 | ROSS, WHITNEY TROTTER | reporter.nih.gov |
| Quantitative proteomic profiling of extracellular vesicles from menstrualeffluent for the discovery of non-invasive diagnostic biomarkers of endometriosis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 | $309,897 | September 19, 2022 | August 31, 2024 | SHARMA, PRANAV | reporter.nih.gov |
| Stress strain imaging for detection and characterization of endometriosis, adenomyosis and uterine fibroids | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 | $299,942 | May 1, 2023 | April 30, 2025 | EGOROV, VLADIMIR | reporter.nih.gov |
| The role of hyaluronic acid and its receptors in the pathogenesis of endometriosis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 | $299,804 | August 11, 2023 | July 31, 2025 | SCHENKEN, ROBERT S | reporter.nih.gov |
| Antibody agonist for a G protein-coupled receptor as a treatment for pain in endometriosis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 | $292,942 | June 10, 2022 | May 31, 2024 | TAKEUCHI, TOSHIHIKO | reporter.nih.gov |
| Endometrial immune microenvironment dysfunction in endometriosis pathobiology | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $259,157 | September 5, 2024 | August 31, 2026 | FEYAERTS, DORIEN | reporter.nih.gov |
| The role of neurotrophins in chronic pelvic pain and central sensitization among adolescents and women with endometriosis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 | $255,358 | September 19, 2022 | August 31, 2024 | SHAFRIR, AMY LEE | reporter.nih.gov |
| Neuroimmune communication as a driver of lesion formation and macrophage colonization of the omentum in endometriosis-associated pain | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 | $254,610 | July 15, 2024 | June 30, 2025 | FATTORI, VICTOR | reporter.nih.gov |
| Targeting Reactive Aldehyde Metabolism in Endometriosis as a treatment strategy and a Diagnostic Biomarker | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $237,904 | August 1, 2019 | July 31, 2023 | MCALLISTER, STACY L | reporter.nih.gov |
| Peripheral and central mechanisms of endometriosis pain | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $233,250 | April 1, 2025 | March 31, 2027 | NAHMAN-AVERBUCH, HADAS | reporter.nih.gov |
| Endometriosis, Infertility, and Risk of Stroke | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $230,313 | July 1, 2020 | June 30, 2024 | FARLAND, LESLIE V | reporter.nih.gov |
| A nanoparticle-based approach for surgical imaging and intraoperative treatment of endometriosis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $199,543 | February 20, 2020 | January 31, 2023 | SLAYDEN, OV D | reporter.nih.gov |
| Role of REST in endometriosis-associated progesterone resistance | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $191,250 | May 1, 2020 | April 30, 2023 | NOTHNICK, WARREN B | reporter.nih.gov |
| The Role of Glial Cells in Chronic Pelvic Pain of Endometriosis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $190,247 | September 1, 2020 | August 31, 2023 | NOWAK, ROMANA A. | reporter.nih.gov |
| TET2 as a novel epigenetic regulator for uterine function and fertility | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 | $152,000 | August 8, 2023 | July 31, 2025 | WANG, XIAOQIU | reporter.nih.gov |
| An idiographic approach to the neurobiological underpinnings of adolescent chronic pelvic pain | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $123,156 | September 1, 2025 | August 31, 2027 | HIDALGO LOPEZ, ESMERALDA | reporter.nih.gov |
| An AHEI Dietary Intervention to Reduce Pain in Women with Endometriosis | NIH | National Institute of Nursing Research | 2021 | $121,780 | February 11, 2019 | March 31, 2022 | HARRIS, HOLLY RUTH | reporter.nih.gov |
| The Role of Thromboxane A2 in Vascular Regulation in Women with Endometriosis | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $95,238 | September 1, 2023 | August 31, 2025 | WILLIAMS, AUNI | reporter.nih.gov |
| Monitoring the progression of endometriosis using PET/CT imaging | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2023 | $85,930 | March 1, 2022 | May 31, 2023 | WILSON, RACHEL CATHARINE | reporter.nih.gov |
| Imaging the Uterotubal Junction for Endometriosis Detection | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $83,778 | June 3, 2024 | June 2, 2028 | LONG, DILARA | reporter.nih.gov |
| Cytoskeletal regulation of the Hippo and Notch1 signaling pathways in endometrial stromal cell decidualization and endometriosis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2023 | $78,740 | February 1, 2022 | January 31, 2024 | MOLDOVAN, GENNA | reporter.nih.gov |
| Implications for iron homeostasis and ferroptosis in early pregnancy and endometriosis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $78,052 | April 17, 2025 | April 16, 2028 | THAPA, RUPAK | reporter.nih.gov |
| Biological Roles of Forkhead Box C1 in Pelvic Endometriosis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $66,390 | December 2, 2020 | January 2, 2022 | BURNS, GREGORY WILLIS | reporter.nih.gov |
| Enriched environments: a multi-level integrative medicine intervention for endometriosis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $60,838 | July 1, 2021 | June 30, 2023 | FLORES, IDHALIZ | reporter.nih.gov |
| Immunologic Contributions to the Endometriosis Phenotype | NIH | National Institute of Environmental Health Sciences | 2023 to 2024 | $54,389 | February 1, 2023 | August 18, 2024 | STEPHENS, VICTORIA RENEE | reporter.nih.gov |
| Endometriosis autoantibody target discovery and functional validation. | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $42,656 | September 1, 2025 | August 31, 2029 | KORTBAWI, HANNAH | reporter.nih.gov |
| The role of ARID1A in endometriosis-related infertility | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $30,356 | August 16, 2020 | May 15, 2022 | MARQUARDT, RYAN | reporter.nih.gov |
| Molecular Imaging and Diagnosis of Endometriosis using Mass Spectrometry Technologies | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $1 | May 18, 2021 | August 31, 2021 | SCHIAVINATO EBERLIN, LIVIA | reporter.nih.gov |
| Functional Genomics Across an Ethnically and Racially Diverse Endometriosis Population | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 | $1 | January 1, 2024 | March 29, 2024 | LAWRENSON, KATE | reporter.nih.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| Baylor College of Medicine | Houston, TX | 7 | $11.4 million | 0 | $0 |
| Michigan State University | East Lansing, MI | 8 | $10.1 million | 0 | $0 |
| University of Michigan at Ann Arbor | Ann Arbor, MI | 5 | $8 million | 0 | $0 |
| University of California, San Francisco | San Francisco, CA | 3 | $7.6 million | 0 | $0 |
| Endomet Biosciences, INC | Irvine, CA | 2 | $6.4 million | 0 | $0 |
| University of Texas HLTH Science Center | San Antonio, TX | 5 | $6.2 million | 0 | $0 |
| Mayo Clinic Rochester | Rochester, MN | 1 | $4.4 million | 0 | $0 |
| Boston Children's Hospital | Boston, MA | 4 | $3.9 million | 0 | $0 |
| University of Kansas Medical Center | Kansas City, KS | 3 | $3.7 million | 0 | $0 |
| Northwestern University at Chicago | Chicago, IL | 3 | $3.6 million | 0 | $0 |
| Yale University | New Haven, CT | 1 | $3.5 million | 0 | $0 |
| Pennsylvania State Univ University Park | University Park, PA | 2 | $3.4 million | 0 | $0 |
| Brigham and Women's Hospital | Boston, MA | 2 | $3.2 million | 0 | $0 |
| Washington University | Saint Louis, MO | 4 | $3.1 million | 0 | $0 |
| Massachusetts Institute of Technology | Cambridge, MA | 2 | $3 million | 0 | $0 |
| Indiana University Indianapolis | Indianapolis, IN | 2 | $3 million | 0 | $0 |
| Harvard University | Cambridge, MA | 1 | $2.5 million | 0 | $0 |
| Oregon State University | Corvallis, OR | 1 | $2.4 million | 0 | $0 |
| University of Utah | Salt Lake City, UT | 1 | $2.4 million | 0 | $0 |
| Washington State University | Pullman, WA | 1 | $2.4 million | 0 | $0 |
| Nextgenjane, Inc. | Oakland, CA | 2 | $2.3 million | 0 | $0 |
| University of Missouri-Columbia | Columbia, MO | 1 | $2.1 million | 0 | $0 |
| University of Pennsylvania | Philadelphia, PA | 1 | $2 million | 0 | $0 |
| Johns Hopkins University | Baltimore, MD | 1 | $2 million | 0 | $0 |
| Fred Hutchinson Cancer Center | Seattle, WA | 3 | $1.9 million | 0 | $0 |
| Sur180 Therapeutics, LLC | Mcallen, TX | 2 | $1.6 million | 0 | $0 |
| Endeavor Health Clinical Operations | Evanston, IL | 1 | $1.6 million | 0 | $0 |
| Texas A&M University | College Station, TX | 1 | $1.3 million | 0 | $0 |
| University of Cincinnati | Cincinnati, OH | 1 | $1.3 million | 0 | $0 |
| Henry Ford Health + Michigan State University Health Sciences | East Lansing, MI | 2 | $1.1 million | 0 | $0 |
| George Mason University | Fairfax, VA | 1 | $1.1 million | 0 | $0 |
| University of Arizona | Tucson, AZ | 3 | $923,491 | 0 | $0 |
| Stanford University | Stanford, CA | 2 | $847,793 | 0 | $0 |
| University of Illinois at Urbana-Champaign | Urbana, IL | 2 | $833,296 | 0 | $0 |
| University of Colorado Denver | Aurora, CO | 1 | $800,046 | 0 | $0 |
| Emory University | Atlanta, GA | 2 | $766,377 | 0 | $0 |
| Columbia University Health Sciences | New York, NY | 1 | $704,700 | 0 | $0 |
| Univ of Massachusetts Med SCH Worcester | Worcester, MA | 1 | $584,074 | 0 | $0 |
| Morehouse School of Medicine | Atlanta, GA | 1 | $578,397 | 0 | $0 |
| Ponce School of Medicine | Ponce, PR | 2 | $531,238 | 0 | $0 |
| Univ of North Carolina Chapel Hill | Chapel Hill, NC | 1 | $508,679 | 0 | $0 |
| Scripps Research Institute, the | La Jolla, CA | 1 | $506,000 | 0 | $0 |
| Magee-Women's Res Inst and Foundation | Pittsburgh, PA | 1 | $464,075 | 0 | $0 |
| Cicerodx, Inc. | Huntington Beach, CA | 1 | $463,322 | 0 | $0 |
| University of Delaware | Newark, DE | 1 | $430,063 | 0 | $0 |
| Duke University | Durham, NC | 1 | $429,718 | 0 | $0 |
| University of Florida | Gainesville, FL | 1 | $419,375 | 0 | $0 |
| Serentrix, LLC | Exton, PA | 1 | $384,418 | 0 | $0 |
| Lazarus 3D, Inc. | Philomath, OR | 1 | $371,012 | 0 | $0 |
| Xosomix LLC | San Diego, CA | 1 | $309,897 | 0 | $0 |
| Advanced Tactile Imaging, Inc. | Trenton, NJ | 1 | $299,942 | 0 | $0 |
| Abalone Bio, Inc. | Emeryville, CA | 1 | $292,942 | 0 | $0 |
| Oregon Health & Science University | Portland, OR | 2 | $285,473 | 0 | $0 |
| North Carolina State University | Raleigh, NC | 1 | $152,000 | 0 | $0 |
| Fred Hutchinson Cancer Research Center | Seattle, WA | 1 | $121,780 | 0 | $0 |
| Vanderbilt University | Nashville, TN | 1 | $54,389 | 0 | $0 |
| University of Texas at Austin | Austin, TX | 1 | $1 | 0 | $0 |
| Cedars-Sinai Medical Center | Los Angeles, CA | 1 | $1 | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 53 | $31,963,130 | 0 | $0 |
| 2024 | 45 | $21,824,449 | 0 | $0 |
| 2023 | 55 | $27,044,764 | 0 | $0 |
| 2022 | 50 | $25,727,530 | 0 | $0 |
| 2021 | 40 | $17,973,790 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 4, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-04). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.